cGMP levels in kidney, heart and liver, and NO_x⁻ and IL-6 levels in plasma.

<p>(A–C) cGMP levels in whole kidney (A), heart (B) and liver (C) homogenates, respectively, 2 h post-treatment (n = 3). (D) Circulating NO_x⁻ levels in plasma, and (E) IL-6 levels in plasma, 2 h post-treatment (n = 3). Data are means ± SEM and comparisons were made between baseline (PBS) and LPS-challenged vehicle control animals (*), as well as LPS-challenged vehicle control and treatment groups (#) via one-way ANOVA with Fisher's LSD test. ***, p≤0.001; **, p≤0.01 and *, p≤0.05.